Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
about
A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma.Radiosensitization of adenoid cystic carcinoma with MDM2 inhibition.Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells.
P2860
Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@en
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@nl
type
label
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@en
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@nl
prefLabel
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@en
Therapeutic Inhibition of the ...... of Adenoid Cystic Carcinomas.
@nl
P2093
P2860
P1476
Therapeutic Inhibition of the ...... e of Adenoid Cystic Carcinomas
@en
P2093
Felipe Nör
Gerson A Acasigua
Jacques E Nör
Joseph I Helman
Kristy A Warner
Manoel Sant'Ana Filho
Samuel A Kerk
Zhaocheng Zhang
P2860
P304
P356
10.1158/1078-0432.CCR-16-1235
P407
P577
2016-08-22T00:00:00Z